Immune responses to implants - A review of the implications for the design of immunomodulatory biomaterials

Biomaterials

Volumn 32, Issue 28, 2011, Pages 6692-6709

  Franz, Sandra ^a,d   Rammelt, Stefan ^b,d   Scharnweber, Dieter ^c,d   Simon, Jan C ^a,d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d Matrixengineering Department of Dermatology Venereology and Allergology   (Germany)

Author keywords

Biomaterial integration; Extracellular matrix; Immune response to biomaterials; Immunomodulation

Indexed keywords

COMPLEX INTERACTION; EXTRACELLULAR MATRICES; HEALING PROCESS; HOST IMMUNE RESPONSE; HOST RESPONSE; IMMUNE RESPONSE; IMMUNOMODULATION; IN-DEPTH UNDERSTANDING; WOUND HEALING;

BIOLOGICAL MATERIALS; ENZYME ACTIVITY; IMMUNOLOGY; PHYSIOLOGICAL MODELS;

IMPLANTS (SURGICAL);

BIOMATERIAL;

BIOENGINEERING; CELLULAR IMMUNITY; EXTRACELLULAR MATRIX; HEALING; IMMUNE RESPONSE; IMMUNOMODULATION; IMPLANT; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BIOCOMPATIBLE MATERIALS; COMPLEMENT ACTIVATION; EXTRACELLULAR MATRIX; FOREIGN-BODY REACTION; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; INFLAMMATION; PROSTHESES AND IMPLANTS; WOUND HEALING;

EID: 79960556002     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.078     Document Type: Review

References (257)

1. Williams D.F. On the nature of biomaterials. Biomaterials 2009, 30:5897-5909.
2. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
3. Wilson C.J., Clegg R.E., Leavesley D.I., Pearcy M.J. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng 2005, 11:1-18.
4. Gorbet M.B., Sefton M.V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004, 25:5681-5703.
5. Schmaier A.H. Contact activation: a revision. Thromb Haemost 1997, 78:101-107.
6. Zhuo R., Siedlecki C.A., Vogler E.A. Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces. Biomaterials 2006, 27:4325-4332.
7. Chen X., Wang J., Paszti Z., Wang F., Schrauben J.N., Tarabara V.V., et al. Ordered adsorption of coagulation factor XII on negatively charged polymer surfaces probed by sum frequency generation vibrational spectroscopy. Anal Bioanal Chem 2007, 388:65-72.
8. Vogler E.A., Siedlecki C.A. Contact activation of blood-plasma coagulation. Biomaterials 2009, 30:1857-1869.
9. Zhuo R., Siedlecki C.A., Vogler E.A. Competitive-protein adsorption in contact activation of blood factor XII. Biomaterials 2007, 28:4355-4369.
10. Sperling C., Fischer M., Maitz M.F., Werner C. Blood coagulation on biomaterials requires the combination of distinct activation processes. Biomaterials 2009, 30:4447-4456.
11. Fischer M., Sperling C., Werner C. Synergistic effect of hydrophobic and anionic surface groups triggers blood coagulation in vitro. J Mater Sci Mater Med 2010, 21:931-937.
12. Heemskerk J.W., Bevers E.M., Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002, 88:186-193.
13. Johne J., Blume C., Benz P.M., Pozgajova M., Ullrich M., Schuh K., et al. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma. Biol Chem 2006, 387:173-178.
14. Hu W.J., Eaton J.W., Ugarova T.P., Tang L. Molecular basis of biomaterial-mediated foreign body reactions. Blood 2001, 98:1231-1238.
15. Tang L. Mechanisms of fibrinogen domains: biomaterial interactions. J Biomater Sci Polym Ed 1998, 9:1257-1266.
16. Savage B., Bottini E., Ruggeri Z.M. Interaction of integrin alpha IIb beta 3 with multiple fibrinogen domains during platelet adhesion. J Biol Chem 1995, 270:28812-28817.
17. Rodrigues S.N., Goncalves I.C., Martins M.C., Barbosa M.A., Ratner B.D. Fibrinogen adsorption, platelet adhesion and activation on mixed hydroxyl-/methyl-terminated self-assembled monolayers. Biomaterials 2006, 27:5357-5367.
18. Fischer M., Sperling C., Tengvall P., Werner C. The ability of surface characteristics of materials to trigger leukocyte tissue factor expression. Biomaterials 2010, 31:2498-2507.
19. Nilsson B., Ekdahl K.N., Mollnes T.E., Lambris J.D. The role of complement in biomaterial-induced inflammation. Mol Immunol 2007, 44:82-94.
20. Lhotta K., Wurzner R., Kronenberg F., Oppermann M., Konig P. Rapid activation of the complement system by cuprophane depends on complement component C4. Kidney Int 1998, 53:1044-1051.
21. Hed J., Johansson M., Lindroth M. Complement activation according to the alternate pathway by glass and plastic surfaces and its role in neutrophil adhesion. Immunol Lett 1984, 8:295-299.
22. Sarma J.V., Ward P.A. The complement system. Cell Tissue Res 2011, 343:227-235.
23. Tengvall P., Askendal A., Lundstrom I.I. Ellipsometric in vitro studies on the activation of complement by human immunoglobulins M and G after adsorption to methylated silicon. Colloids Surf B Biointerfaces 2001, 20:51-62.
24. Andersson J., Ekdahl K.N., Larsson R., Nilsson U.R., Nilsson B. C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol 2002, 168:5786-5791.
25. Johnson R.J. Complement activation during extracorporeal therapy: biochemistry, cell biology and clinical relevance. Nephrol Dial Transplant 1994, 9(Suppl. 2):36-45.
26. Andersson J., Ekdahl K.N., Lambris J.D., Nilsson B. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 2005, 26:1477-1485.
27. Karpman D., Manea M., Vaziri-Sani F., Stahl A.L., Kristoffersson A.C. Platelet activation in hemolytic uremic syndrome. Semin Thromb Hemost 2006, 32:128-145.
28. Gorbet M.B., Sefton M.V. Material-induced tissue factor expression but not CD11b upregulation depends on the presence of platelets. J Biomed Mater Res A 2003, 67:792-800.
29. Morley D.J., Feuerstein I.A. Adhesion of polymorphonuclear leukocytes to protein-coated and platelet adherent surfaces. Thromb Haemost 1989, 62:1023-1028.
30. McFarland C.D., Thomas C.H., DeFilippis C., Steele J.G., Healy K.E. Protein adsorption and cell attachment to patterned surfaces. J Biomed Mater Res 2000, 49:200-210.
31. Keselowsky B.G., Bridges A.W., Burns K.L., Tate C.C., Babensee J.E., LaPlaca M.C., et al. Role of plasma fibronectin in the foreign body response to biomaterials. Biomaterials 2007, 28:3626-3631.
32. McNally A.K., Jones J.A., Macewan S.R., Colton E., Anderson J.M. Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. J Biomed Mater Res A 2008, 86:535-543.
33. Kilpadi K.L., Chang P.L., Bellis S.L. Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res 2001, 57:258-267.
34. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
35. Lowell C.A., Berton G. Integrin signal transduction in myeloid leukocytes. J Leukoc Biol 1999, 65:313-320.
36. Jenney C.R., Anderson J.M. Adsorbed serum proteins responsible for surface dependent human macrophage behavior. J Biomed Mater Res 2000, 49:435-447.
37. McNally A.K., Anderson J.M. Complement C3 participation in monocyte adhesion to different surfaces. Proc Natl Acad Sci U S A 1994, 91:10119-10123.
38. Keselowsky B.G., Collard D.M., Garcia A.J. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci U S A 2005, 102:5953-5957.
39. Keselowsky B.G., Collard D.M., Garcia A.J. Surface chemistry modulates focal adhesion composition and signaling through changes in integrin binding. Biomaterials 2004, 25:5947-5954.
40. McNally A.K., Macewan S.R., Anderson J.M. Alpha subunit partners to beta1 and beta2 integrins during IL-4-induced foreign body giant cell formation. J Biomed Mater Res A 2007, 82:568-574.
41. Werr J., Eriksson E.E., Hedqvist P., Lindbom L. Engagement of beta2 integrins induces surface expression of beta1 integrin receptors in human neutrophils. J Leukoc Biol 2000, 68:553-560.
42. McNally A.K., Anderson J.M. Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am J Pathol 2002, 160:621-630.
43. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007, 81:1-5.
44. Babensee J.E. Interaction of dendritic cells with biomaterials. Semin Immunol 2008, 20:101-108.
45. Bennewitz N.L., Babensee J.E. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials 2005, 26:2991-2999.
46. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8:279-289.
47. Grandjean-Laquerriere A., Tabary O., Jacquot J., Richard D., Frayssinet P., Guenounou M., et al. Involvement of toll-like receptor 4 in the inflammatory reaction induced by hydroxyapatite particles. Biomaterials 2007, 28:400-404.
48. Rogers T.H., Babensee J.E. Altered adherent leukocyte profile on biomaterials in toll-like receptor 4 deficient mice. Biomaterials 2010, 31:594-601.
49. Kobayashi S.D., Voyich J.M., Burlak C., DeLeo F.R. Neutrophils in the innate immune response. Arch Immunol Ther Exp (Warsz) 2005, 53:505-517.
50. Tang L., Jennings T.A., Eaton J.W. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci U S A 1998, 95:8841-8846.
51. Zdolsek J., Eaton J.W., Tang L. Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans. J Transl Med 2007, 5:31.
52. Nimeri G., Ohman L., Elwing H., Wettero J., Bengtsson T. The influence of plasma proteins and platelets on oxygen radical production and F-actin distribution in neutrophils adhering to polymer surfaces. Biomaterials 2002, 23:1785-1795.
53. Nimeri G., Majeed M., Elwing H., Ohman L., Wettero J., Bengtsson T. Oxygen radical production in neutrophils interacting with platelets and surface-immobilized plasma proteins: role of tyrosine phosphorylation. J Biomed Mater Res A 2003, 67:439-447.
54. Labow R.S., Meek E., Santerre J.P. Neutrophil-mediated biodegradation of medical implant materials. J Cell Physiol 2001, 186:95-103.
55. Patel J.D., Krupka T., Anderson J.M. iNOS-mediated generation of reactive oxygen and nitrogen species by biomaterial-adherent neutrophils. J Biomed Mater Res A 2007, 80:381-390.
56. Scapini P., Lapinet-Vera J.A., Gasperini S., Calzetti F., Bazzoni F., Cassatella M.A. The neutrophil as a cellular source of chemokines. Immunol Rev 2000, 177:195-203.
57. Hidaka Y., Ito M., Mori K., Yagasaki H., Kafrawy A.H. Histopathological and immunohistochemical studies of membranes of deacetylated chitin derivatives implanted over rat calvaria. J Biomed Mater Res 1999, 46:418-423.
58. VandeVord P.J., Matthew H.W., DeSilva S.P., Mayton L., Wu B., Wooley P.H. Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res 2002, 59:585-590.
59. Park C.J., Gabrielson N.P., Pack D.W., Jamison R.D., Wagoner Johnson A.J. The effect of chitosan on the migration of neutrophil-like HL60 cells, mediated by IL-8. Biomaterials 2009, 30:436-444.
60. Yamashiro S., Kamohara H., Wang J.M., Yang D., Gong W.H., Yoshimura T. Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses. J Leukoc Biol 2001, 69:698-704.
61. Gilroy D.W. The endogenous control of acute inflammation - from onset to resolution. Drug Discov Today Ther Strat 2004, 1:313-319.
62. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
63. Hamilton J.A. Nondisposable materials, chronic inflammation, and adjuvant action. J Leukoc Biol 2003, 73:702-712.
64. Jones J.A., Chang D.T., Meyerson H., Colton E., Kwon I.K., Matsuda T., et al. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A 2007, 83:585-596.
65. Broughton G., Janis J.E., Attinger C.E. The basic science of wound healing. Plast Reconstr Surg 2006, 117:12S-34S.
66. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
67. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
68. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front Biosci 2008, 13:453-461.
69. Zhang X., Mosser D.M. Macrophage activation by endogenous danger signals. J Pathol 2008, 214:161-178.
70. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992, 176:287-292.
71. Gratchev A., Guillot P., Hakiy N., Politz O., Orfanos C.E., Schledzewski K., et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 2001, 53:386-392.
72. Gratchev A., Kzhyshkowska J., Utikal J., Goerdt S. Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scand J Immunol 2005, 61:10-17.
73. Mosser D.M. The many faces of macrophage activation. J Leukoc Biol 2003, 73:209-212.
74. Gerber J.S., Mosser D.M. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J Immunol 2001, 166:6861-6868.
75. Bellingan G.J., Xu P., Cooksley H., Cauldwell H., Shock A., Bottoms S., et al. Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation. J Exp Med 2002, 196:1515-1521.
76. Stout R.D., Jiang C., Matta B., Tietzel I., Watkins S.K., Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005, 175:342-349.
77. Franz S., Hoeve M.A., Wickert S., Janko C., Dransfield I. Clearance of apo Nph induces an immunosuppressive response in pro-inflammatory type-1 and anti-inflammatory type-2 MPhi. Autoimmunity 2009, 42:275-277.
78. Xia Z., Triffitt J.T. A review on macrophage responses to biomaterials. Biomed Mater 2006, 1:R1-R9.
79. DeFife K.M., Jenney C.R., McNally A.K., Colton E., Anderson J.M. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J Immunol 1997, 158:3385-3390.
80. Kao W.J., McNally A.K., Hiltner A., Anderson J.M. Role for interleukin-4 in foreign-body giant cell formation on a poly(etherurethane urea) in vivo. J Biomed Mater Res 1995, 29:1267-1275.
81. McNally A.K., Anderson J.M. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 1995, 147:1487-1499.
82. Brodbeck W.G., Macewan M., Colton E., Meyerson H., Anderson J.M. Lymphocytes and the foreign body response: lymphocyte enhancement of macrophage adhesion and fusion. J Biomed Mater Res A 2005, 74:222-229.
83. Rodriguez A., Macewan S.R., Meyerson H., Kirk J.T., Anderson J.M. The foreign body reaction in T-cell-deficient mice. J Biomed Mater Res A 2009, 90:106-113.
84. Kyriakides T.R., Foster M.J., Keeney G.E., Tsai A., Giachelli C.M., Clark-Lewis I., et al. The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol 2004, 165:2157-2166.
85. Helming L., Gordon S. Molecular mediators of macrophage fusion. Trends Cell Biol 2009, 19:514-522.
86. Helming L., Gordon S. Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. Eur J Immunol 2007, 37:33-42.
87. McNally A.K., DeFife K.M., Anderson J.M. Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity. Am J Pathol 1996, 149:975-985.
88. Cui W., Ke J.Z., Zhang Q., Ke H.Z., Chalouni C., Vignery A. The intracellular domain of CD44 promotes the fusion of macrophages. Blood 2006, 107:796-805.
89. Han X., Sterling H., Chen Y., Saginario C., Brown E.J., Frazier W.A., et al. CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J Biol Chem 2000, 275:37984-37992.
90. Yagi M., Miyamoto T., Sawatani Y., Iwamoto K., Hosogane N., Fujita N., et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 2005, 202:345-351.
91. Moreno J.L., Mikhailenko I., Tondravi M.M., Keegan A.D. IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. J Leukoc Biol 2007, 82:1542-1553.
92. Anderson J.M. Multinucleated giant cells. Curr Opin Hematol 2000, 7:40-47.
93. Xia Z.D., Zhu T.B., Du J.Y., Zheng Q.X., Wang L., Li S.P., et al. Macrophages in degradation of collagen/hydroxylapatite(CHA), beta-tricalcium phosphate ceramics (TCP) artificial bone graft. An in vivo study. Chin Med J (Engl) 1994, 107:845-849.
94. Christenson E.M., Anderson J.M., Hiltner A. Oxidative mechanisms of poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo and in vitro correlations. J Biomed Mater Res A 2004, 70:245-255.
95. Santerre J.P., Woodhouse K., Laroche G., Labow R.S. Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials. Biomaterials 2005, 26:7457-7470.
96. Kalbacova M., Roessler S., Hempel U., Tsaryk R., Peters K., Scharnweber D., et al. The effect of electrochemically simulated titanium cathodic corrosion products on ROS production and metabolic activity of osteoblasts and monocytes/macrophages. Biomaterials 2007, 28:3263-3272.
97. Luttikhuizen D.T., van Amerongen M.J., de Feijter P.C., Petersen A.H., Harmsen M.C., van Luyn M.J. The correlation between difference in foreign body reaction between implant locations and cytokine and MMP expression. Biomaterials 2006, 27:5763-5770.
98. Jones J.A., McNally A.K., Chang D.T., Qin L.A., Meyerson H., Colton E., et al. Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials. J Biomed Mater Res A 2008, 84:158-166.
99. MacLauchlan S., Skokos E.A., Meznarich N., Zhu D.H., Raoof S., Shipley J.M., et al. Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9. J Leukoc Biol 2009, 85:617-626.
100. Zambuzzi W.F., Paiva K.B., Menezes R., Oliveira R.C., Taga R., Granjeiro J.M. MMP-9 and CD68(+) cells are required for tissue remodeling in response to natural hydroxyapatite. J Mol Histol 2009, 40:301-309.
101. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17:463-516.
102. Liu Y., Min D., Bolton T., Nube V., Twigg S.M., Yue D.K., et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 2009, 32:117-119.
103. Gretzer C., Emanuelsson L., Liljensten E., Thomsen P. The inflammatory cell influx and cytokines changes during transition from acute inflammation to fibrous repair around implanted materials. J Biomater Sci Polym Ed 2006, 17:669-687.
104. Anderson J.M., Jones J.A. Phenotypic dichotomies in the foreign body reaction. Biomaterials 2007, 28:5114-5120.
105. Rodriguez A., Meyerson H., Anderson J.M. Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. J Biomed Mater Res A 2009, 89:152-159.
106. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007, 127:514-525.
107. Moseley R., Hilton J.R., Waddington R.J., Harding K.G., Stephens P., Thomas D.W. Comparison of oxidative stress biomarker profiles between acute and chronic wound environments. Wound Repair Regen 2004, 12:419-429.
108. Ratner B.D. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Release 2002, 78:211-218.
109. Ratner B.D., Bryant S.J. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng 2004, 6:41-75.
110. Diegelmann R.F., Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004, 9:283-289.
111. Stramer B.M., Mori R., Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 2007, 127:1009-1017.
112. Prantl L., Fichtner-Feigl S., Hofstaedter F., Lenich A., Eisenmann-Klein M., Schreml S. Flow cytometric analysis of peripheral blood lymphocyte subsets in patients with silicone breast implants. Plast Reconstr Surg 2008, 121:25-30.
113. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol 2002, 23:445-449.
114. Rutella S., Danese S., Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006, 108:1435-1440.
115. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001, 194:769-779.
116. Steinman R.M., Hawiger D., Liu K., Bonifaz L., Bonnyay D., Mahnke K., et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann N Y Acad Sci 2003, 987:15-25.
117. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000, 192:1213-1222.
118. Menges M., Rossner S., Voigtlander C., Schindler H., Kukutsch N.A., Bogdan C., et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002, 195:15-21.
119. Vigouroux S., Yvon E., Biagi E., Brenner M.K. Antigen-induced regulatory T cells. Blood 2004, 104:26-33.
120. Geissmann F., Revy P., Regnault A., Lepelletier Y., Dy M., Brousse N., et al. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 1999, 162:4567-4575.
121. Sato K., Yamashita N., Matsuyama T. Human peripheral blood monocyte-derived interleukin-10-induced semi-mature dendritic cells induce anergic CD4(+) and CD8(+) T cells via presentation of the internalized soluble antigen and cross-presentation of the phagocytosed necrotic cellular fragments. Cell Immunol 2002, 215:186-194.
122. Rutella S., Bonanno G., Procoli A., Mariotti A., de Ritis D.G., Curti A., et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 2006, 108:218-227.
123. Rutella S., Bonanno G., Pierelli L., Mariotti A., Capoluongo E., Contemi A.M., et al. Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur J Immunol 2004, 34:1291-1302.
124. Della B.S., Nicola S., Timofeeva I., Villa M.L., Santoro A., Berardi A.C. Are interleukin-16 and thrombopoietin new tools for the in vitro generation of dendritic cells?. Blood 2004, 104:4020-4028.
125. Frick J.S., Grunebach F., Autenrieth I.B. Immunomodulation by semi-mature dendritic cells: a novel role of toll-like receptors and interleukin-6. Int J Med Microbiol 2010, 300:19-24.
126. Babensee J.E., Stein M.M., Moore L.K. Interconnections between inflammatory and immune responses in tissue engineering. Ann N Y Acad Sci 2002, 961:360-363.
127. Yoshida M., Babensee J.E. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A 2004, 71:45-54.
128. Acharya A.P., Dolgova N.V., Clare-Salzler M.J., Keselowsky B.G. Adhesive substrate-modulation of adaptive immune responses. Biomaterials 2008, 29:4736-4750.
129. Kohl K., Schnautz S., Pesch M., Klein E., Aumailley M., Bieber T., et al. Subpopulations of human dendritic cells display a distinct phenotype and bind differentially to proteins of the extracellular matrix. Eur J Cell Biol 2007, 86:719-730.
130. Brand U., Bellinghausen I., Enk A.H., Jonuleit H., Becker D., Knop J., et al. Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur J Immunol 1998, 28:1673-1680.
131. Babensee J.E., Paranjpe A. Differential levels of dendritic cell maturation on different biomaterials used in combination products. J Biomed Mater Res A 2005, 74:503-510.
132. Yoshida M., Babensee J.E. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. J Biomed Mater Res A 2006, 79:393-408.
133. Padovan E., Landmann R.M., De L.G. How pattern recognition receptor triggering influences T cell responses: a new look into the system. Trends Immunol 2007, 28:308-314.
134. Chang D.T., Colton E., Anderson J.M. Paracrine and juxtacrine lymphocyte enhancement of adherent macrophage and foreign body giant cell activation. J Biomed Mater Res A 2009, 89:490-498.
135. Chang D.T., Jones J.A., Meyerson H., Colton E., Kwon I.K., Matsuda T., et al. Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production. J Biomed Mater Res A 2008, 87:676-687.
136. Marques A.P., Reis R.L., Hunt J.A. Cytokine secretion from mononuclear cells cultured in vitro with starch-based polymers and poly-l-lactide. J Biomed Mater Res A 2004, 71:419-429.
137. Rodriguez A., Anderson J.M. Evaluation of clinical biomaterial surface effects on T lymphocyte activation. J Biomed Mater Res A 2010, 92:214-220.
138. Katzin W.E., Feng L.J., Abbuhl M., Klein M.A. Phenotype of lymphocytes associated with the inflammatory reaction to silicone gel breast implants. Clin Diagn Lab Immunol 1996, 3:156-161.
139. de Fougerolles A.R., Koteliansky V.E. Regulation of monocyte gene expression by the extracellular matrix and its functional implications. Immunol Rev 2002, 186:208-220.
140. Forster R., valos-Misslitz A.C., Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008, 8:362-371.
141. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
142. Daamen W.F., van Moerkerk H.T., Hafmans T., Buttafoco L., Poot A.A., Veerkamp J.H., et al. Preparation and evaluation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds for tissue engineering. Biomaterials 2003, 24:4001-4009.
143. Badylak S.F. Regenerative medicine and developmental biology: the role of the extracellular matrix. Anat Rec B New Anat 2005, 287:36-41.
144. Dudhia J. Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci 2005, 62:2241-2256.
145. Taylor K.R., Gallo R.L. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 2006, 20:9-22.
146. Korpos E., Wu C., Song J., Hallmann R., Sorokin L. Role of the extracellular matrix in lymphocyte migration. Cell Tissue Res 2010, 339:47-57.
147. Kreuger J., Spillmann D., Li J.P., Lindahl U. Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol 2006, 174:323-327.
148. Schultz G.S., Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009, 17:153-162.
149. Rosso F., Giordano A., Barbarisi M., Barbarisi A. From cell-ECM interactions to tissue engineering. J Cell Physiol 2004, 199:174-180.
150. Chen Q., Sivakumar P., Barley C., Peters D.M., Gomes R.R., Farach-Carson M.C., et al. Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by modulating assembly of latent TGF-beta-binding protein-1. J Biol Chem 2007, 282:26418-26430.
151. Mott J.D., Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004, 16:558-564.
152. McCawley L.J., Matrisian L.M. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 2001, 13:534-540.
153. Sheu B.C., Hsu S.M., Ho H.N., Lien H.C., Huang S.C., Lin R.H. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res 2001, 61:237-242.
154. Endo K., Takino T., Miyamori H., Kinsen H., Yoshizaki T., Furukawa M., et al. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 2003, 278:40764-40770.
155. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2:737-744.
156. Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R., et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000, 151:879-889.
157. Dallas S.L., Rosser J.L., Mundy G.R., Bonewald L.F. Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 2002, 277:21352-21360.
158. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000, 14:163-176.
159. Hangai M., Kitaya N., Xu J., Chan C.K., Kim J.J., Werb Z., et al. Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis. Am J Pathol 2002, 161:1429-1437.
160. Pirila E., Sharabi A., Salo T., Quaranta V., Tu H., Heljasvaara R., et al. Matrix metalloproteinases process the laminin-5 gamma 2-chain and regulate epithelial cell migration. Biochem Biophys Res Commun 2003, 303:1012-1017.
161. Baker A.H., Edwards D.R., Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002, 115:3719-3727.
162. Murphy G., Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med 2008, 29:290-308.
163. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003, 92:827-839.
164. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174.
165. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002, 90:251-262.
166. Smeets T.J., Kraan M.C., Galjaard S., Youssef P.P., Smith M.D., Tak P.P. Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA. Ann Rheum Dis 2001, 60:561-565.
167. Streuli C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 1999, 11:634-640.
168. Ratner B.D., Allan A.S., Schoen F.J., Lemons J.E. Biomaterials science: an introduction to materials in medicine 2004, 2nd ed.
169. Ratner B.D. The engineering of biomaterials exhibiting recognition and specificity. J Mol Recognit 1996, 9:617-625.
170. Rungsiyakull C., Li Q., Sun G., Li W., Swain M.V. Surface morphology optimization for osseointegration of coated implants. Biomaterials 2010, 31:7196-7204.
171. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Muller W., et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010, 184:3964-3977.
172. Mirza R., DiPietro L.A., Koh T.J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009, 175:2454-2462.
173. Bradley S.G., White K.L., McCay J.A., Brown R.D., Musgrove D.L., Wilson S., et al. Immunotoxicity of 180 day exposure to polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice. Drug Chem Toxicol 1994, 17:221-269.
174. Smith M.J., White K.L., Smith D.C., Bowlin G.L. In vitro evaluations of innate and acquired immune responses to electrospun polydioxanone-elastin blends. Biomaterials 2009, 30:149-159.
175. Smith M.J., Smith D.C., Bowlin G.L., White K.L. Modulation of murine innate and acquired immune responses following in vitro exposure to electrospun blends of collagen and polydioxanone. J Biomed Mater Res A 2010, 93:793-806.
176. Scotchford C.A., Gilmore C.P., Cooper E., Leggett G.J., Downes S. Protein adsorption and human osteoblast-like cell attachment and growth on alkylthiol on gold self-assembled monolayers. J Biomed Mater Res 2002, 59:84-99.
177. Dinnes D.L., Marcal H., Mahler S.M., Santerre J.P., Labow R.S. Material surfaces affect the protein expression patterns of human macrophages: a proteomics approach. J Biomed Mater Res A 2007, 80:895-908.
178. Brodbeck W.G., Patel J., Voskerician G., Christenson E., Shive M.S., Nakayama Y., et al. Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proc Natl Acad Sci U S A 2002, 99:10287-10292.
179. Yim E.K., Leong K.W. Significance of synthetic nanostructures in dictating cellular response. Nanomedicine 2005, 1:10-21.
180. Fink J., Fuhrmann R., Scharnweber T., Franke R.P. Stimulation of monocytes and macrophages: possible influence of surface roughness. Clin Hemorheol Microcirc 2008, 39:205-212.
181. Schulte V.A., Diez M., Moller M., Lensen M.C. Surface topography induces fibroblast adhesion on intrinsically nonadhesive poly(ethylene glycol) substrates. Biomacromolecules 2009, 10:2795-2801.
182. Andersson A.S., Backhed F., von E.A., Richter-Dahlfors A., Sutherland D., Kasemo B. Nanoscale features influence epithelial cell morphology and cytokine production. Biomaterials 2003, 24:3427-3436.
183. Dalby M.J., Riehle M.O., Johnstone H., Affrossman S., Curtis A.S. In vitro reaction of endothelial cells to polymer demixed nanotopography. Biomaterials 2002, 23:2945-2954.
184. Chen S., Jones J.A., Xu Y., Low H.Y., Anderson J.M., Leong K.W. Characterization of topographical effects on macrophage behavior in a foreign body response model. Biomaterials 2010, 31:3479-3491.
185. Boontheekul T., Mooney D.J. Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol 2003, 14:559-565.
186. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385-4415.
187. Shin H., Jo S., Mikos A.G. Biomimetic materials for tissue engineering. Biomaterials 2003, 24:4353-4364.
188. Kao W.J., Lee D., Schense J.C., Hubbell J.A. Fibronectin modulates macrophage adhesion and FBGC formation: the role of RGD, PHSRN, and PRRARV domains. J Biomed Mater Res 2001, 55:79-88.
189. Kao W.J., Liu Y. Utilizing biomimetic oligopeptides to probe fibronectin-integrin binding and signaling in regulating macrophage function in vitro and in vivo. Front Biosci 2001, 6:D992-D999.
190. Kao W.J., Lee D. In vivo modulation of host response and macrophage behavior by polymer networks grafted with fibronectin-derived biomimetic oligopeptides: the role of RGD and PHSRN domains. Biomaterials 2001, 22:2901-2909.
191. Schmidt D.R., Kao W.J. Monocyte activation in response to polyethylene glycol hydrogels grafted with RGD and PHSRN separated by interpositional spacers of various lengths. J Biomed Mater Res A 2007, 83:617-625.
192. Zhu J., Tang C., Kottke-Marchant K., Marchant R.E. Design and synthesis of biomimetic hydrogel scaffolds with controlled organization of cyclic RGD peptides. Bioconjug Chem 2009, 20:333-339.
193. VandeVondele S., Voros J., Hubbell J.A. RGD-grafted poly-l-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol Bioeng 2003, 82:784-790.
194. Dalsin J.L., Hu B.H., Lee B.P., Messersmith P.B. Mussel adhesive protein mimetic polymers for the preparation of nonfouling surfaces. J Am Chem Soc 2003, 125:4253-4258.
195. Shen M., Pan Y.V., Wagner M.S., Hauch K.D., Castner D.G., Ratner B.D., et al. Inhibition of monocyte adhesion and fibrinogen adsorption on glow discharge plasma deposited tetraethylene glycol dimethyl ether. J Biomater Sci Polym Ed 2001, 12:961-978.
196. Monchaux E., Vermette P. Bioactive microarrays immobilized on low-fouling surfaces to study specific endothelial cell adhesion. Biomacromolecules 2007, 8:3668-3673.
197. Wang D.A., Ji J., Sun Y.H., Shen J.C., Feng L.X., Elisseeff J.H. In situ immobilization of proteins and RGD peptide on polyurethane surfaces via poly(ethylene oxide) coupling polymers for human endothelial cell growth. Biomacromolecules 2002, 3:1286-1295.
198. Duggal S., Fronsdal K.B., Szoke K., Shahdadfar A., Melvik J.E., Brinchmann J.E. Phenotype and gene expression of human mesenchymal stem cells in alginate scaffolds. Tissue Eng Part A 2009, 15:1763-1773.
199. Franchimont D., Kino T., Galon J., Meduri G.U., Chrousos G. Glucocorticoids and inflammation revisited: the state of the art. NIH clinical staff conference. Neuroimmunomodulation 2002, 10:247-260.
200. Morais J.M., Papadimitrakopoulos F., Burgess D.J. Biomaterials/tissue interactions: possible solutions to overcome foreign body response. AAPS J 2010, 12:188-196.
201. Patil S.D., Papadimitrakopoulos F., Burgess D.J. Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control. Diabetes Technol Ther 2004, 6:887-897.
202. Patil S.D., Papadmitrakopoulos F., Burgess D.J. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release 2007, 117:68-79.
203. Norton L.W., Koschwanez H.E., Wisniewski N.A., Klitzman B., Reichert W.M. Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. J Biomed Mater Res A 2007, 81:858-869.
204. Hetrick E.M., Prichard H.L., Klitzman B., Schoenfisch M.H. Reduced foreign body response at nitric oxide-releasing subcutaneous implants. Biomaterials 2007, 28:4571-4580.
205. Gifford R., Batchelor M.M., Lee Y., Gokulrangan G., Meyerhoff M.E., Wilson G.S. Mediation of in vivo glucose sensor inflammatory response via nitric oxide release. J Biomed Mater Res A 2005, 75:755-766.
206. Schwentker A., Vodovotz Y., Weller R., Billiar T.R. Nitric oxide and wound repair: role of cytokines?. Nitric Oxide 2002, 7:1-10.
207. Bogdan C. Regulation of lymphocytes by nitric oxide. Methods Mol Biol 2011, 677:375-393.
208. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
209. Martin P., Leibovich S.J. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005, 15:599-607.
210. Chung A.S., Kao W.J. Fibroblasts regulate monocyte response to ECM-derived matrix: the effects on monocyte adhesion and the production of inflammatory, matrix remodeling, and growth factor proteins. J Biomed Mater Res A 2009, 89:841-853.
211. Oshikawa K., Yamasawa H., Sugiyama Y. Human lung fibroblasts inhibit macrophage inflammatory protein-1alpha production by lipopolysaccharide-stimulated macrophages. Biochem Biophys Res Commun 2003, 312:650-655.
212. Vancheri C., Mastruzzo C., Tomaselli V., Sortino M.A., D'Amico L., Bellistri G., et al. Normal human lung fibroblasts differently modulate interleukin-10 and interleukin-12 production by monocytes: implications for an altered immune response in pulmonary chronic inflammation. Am J Respir Cell Mol Biol 2001, 25:592-599.
213. Schirmer C., Klein C., von B.M., Simon J.C., Saalbach A. Human fibroblasts support the expansion of IL-17 producing T-cells via up-regulation of IL-23 production by dendritic cells. Blood 2010.
214. Saalbach A., Klein C., Schirmer C., Briest W., Anderegg U., Simon J.C. Dermal fibroblasts promote the migration of dendritic cells. J Invest Dermatol 2010, 130:444-454.
215. Sundararaj K.P., Samuvel D.J., Li Y., Sanders J.J., Lopes-Virella M.F., Huang Y. Interleukin-6 released from fibroblasts is essential for up-regulation of matrix metalloproteinase-1 expression by U937 macrophages in coculture: cross-talking between fibroblasts and U937 macrophages exposed to high glucose. J Biol Chem 2009, 284:13714-13724.
216. Li B., Davidson J.M., Guelcher S.A. The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds. Biomaterials 2009, 30:3486-3494.
217. De la Riva B., Sanchez E., Hernandez A., Reyes R., Tamimi F., Lopez-Cabarcos E., et al. Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Control Release 2010, 143:45-52.
218. Pieper J.S., Hafmans T., van Wachem P.B., van Luyn M.J., Brouwer L.A., Veerkamp J.H., et al. Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res 2002, 62:185-194.
219. Stefonek T.J., Masters K.S. Immobilized gradients of epidermal growth factor promote accelerated and directed keratinocyte migration. Wound Repair Regen 2007, 15:847-855.
220. Hosgood G. Wound healing. The role of platelet-derived growth factor and transforming growth factor beta. Vet Surg 1993, 22:490-495.
221. Hoffman A.S. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002, 54:3-12.
222. Zhu J. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials 2010, 31:4639-4656.
223. Geutjes P.J., Daamen W.F., Buma P., Feitz W.F., Faraj K.A., van Kuppevelt T.H. From molecules to matrix: construction and evaluation of molecularly defined bioscaffolds. Adv Exp Med Biol 2006, 585:279-295.
224. Valentin J.E., Badylak J.S., McCabe G.P., Badylak S.F. Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J Bone Joint Surg Am 2006, 88:2673-2686.
225. Nagai M., Hayakawa T., Fukatsu A., Yamamoto M., Fukumoto M., Nagahama F., et al. In vitro study of collagen coating of titanium implants for initial cell attachment. Dent Mater J 2002, 21:250-260.
226. Morra M., Cassinelli C., Meda L., Fini M., Giavaresi G., Giardino R. Surface analysis and effects on interfacial bone microhardness of collagen-coated titanium implants: a rabbit model. Int J Oral Maxillofac Implants 2005, 20:23-30.
227. Rammelt S., Schulze E., Bernhardt R., Hanisch U., Scharnweber D., Worch H., et al. Coating of titanium implants with type-I collagen. J Orthop Res 2004, 22:1025-1034.
228. Geissler U., Hempel U., Wolf C., Scharnweber D., Worch H., Wenzel K. Collagen type I-coating of Ti6Al4V promotes adhesion of osteoblasts. J Biomed Mater Res 2000, 51:752-760.
229. Becker D., Geissler U., Hempel U., Bierbaum S., Scharnweber D., Worch H., et al. Proliferation and differentiation of rat calvarial osteoblasts on type I collagen-coated titanium alloy. J Biomed Mater Res 2002, 59:516-527.
230. Schmidmaier G., Lucke M., Schwabe P., Raschke M., Haas N.P., Wildemann B. Collective review: bioactive implants coated with poly(d,l-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. J Long Term Eff Med Implants 2006, 16:61-69.
231. Rammelt S., Illert T., Bierbaum S., Scharnweber D., Zwipp H., Schneiders W. Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate. Biomaterials 2006, 27:5561-5571.
232. Nakamura H.K., Butz F., Saruwatari L., Ogawa T. A role for proteoglycans in mineralized tissue-titanium adhesion. J Dent Res 2007, 86:147-152.
233. Stadlinger B., Pilling E., Huhle M., Mai R., Bierbaum S., Scharnweber D., et al. Evaluation of osseointegration of dental implants coated with collagen, chondroitin sulphate and BMP-4: an animal study. Int J Oral Maxillofac Surg 2008, 37:54-59.
234. Hintze V., Moeller S., Schnabelrauch M., Bierbaum S., Viola M., Worch H., et al. Modifications of hyaluronan influence the interaction with human bone morphogenetic protein-4 (hBMP-4). Biomacromolecules 2009, 10:3290-3297.
235. Wollenweber M., Domaschke H., Hanke T., Boxberger S., Schmack G., Gliesche K., et al. Mimicked bioartificial matrix containing chondroitin sulphate on a textile scaffold of poly(3-hydroxybutyrate) alters the differentiation of adult human mesenchymal stem cells. Tissue Eng 2006, 12:345-359.
236. Bierbaum S., Douglas T., Hanke T., Scharnweber D., Tippelt S., Monsees T.K., et al. Collageneous matrix coatings on titanium implants modified with decorin and chondroitin sulfate: characterization and influence on osteoblastic cells. J Biomed Mater Res A 2006, 77:551-562.
237. Rammelt S., Heck C., Bernhardt R., Bierbaum S., Scharnweber D., Goebbels J., et al. In vivo effects of coating loaded and unloaded Ti implants with collagen, chondroitin sulfate, and hydroxyapatite in the sheep tibia. J Orthop Res 2007, 25:1052-1061.
238. Schneiders W., Reinstorf A., Ruhnow M., Rehberg S., Heineck J., Hinterseher I., et al. Effect of chondroitin sulphate on material properties and bone remodelling around hydroxyapatite/collagen composites. J Biomed Mater Res A 2008, 85:638-645.
239. Schneiders W., Reinstorf A., Biewener A., Serra A., Grass R., Kinscher M., et al. In vivo effects of modification of hydroxyapatite/collagen composites with and without chondroitin sulphate on bone remodeling in the sheep tibia. J Orthop Res 2009, 27:15-21.
240. Stadlinger B., Pilling E., Mai R., Bierbaum S., Berhardt R., Scharnweber D., et al. Effect of biological implant surface coatings on bone formation, applying collagen, proteoglycans, glycosaminoglycans and growth factors. J Mater Sci Mater Med 2008, 19:1043-1049.
241. Rammelt S., Neumann M., Hanisch U., Reinstorf A., Pompe W., Zwipp H., et al. Osteocalcin enhances bone remodeling around hydroxyapatite/collagen composites. J Biomed Mater Res A 2005, 73:284-294.
242. Schneiders W., Reinstorf A., Pompe W., Grass R., Biewener A., Holch M., et al. Effect of modification of hydroxyapatite/collagen composites with sodium citrate, phosphoserine, phosphoserine/RGD-peptide and calcium carbonate on bone remodelling. Bone 2007, 40:1048-1059.
243. Mummery R.S., Rider C.C. Characterization of the heparin-binding properties of IL-6. J Immunol 2000, 165:5671-5679.
244. Salek-Ardakani S., Arrand J.R., Shaw D., Mackett M. Heparin and heparan sulfate bind interleukin-10 and modulate its activity. Blood 2000, 96:1879-1888.
245. Witt D.P., Lander A.D. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 1994, 4:394-400.
246. du Souich P., Garcia A.G., Verges J., Montell E. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med 2009, 13:1451-1463.
247. Vallieres M., du S.P. Modulation of inflammation by chondroitin sulfate. Osteoarthritis Cartilage 2010, 18(Suppl. 1):S1-S6.
248. Herrero-Beaumont G., Marcos M.E., Sanchez-Pernaute O., Granados R., Ortega L., Montell E., et al. Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br J Pharmacol 2008, 154:843-851.
249. Campo G.M., Avenoso A., Campo S., Ferlazzo A., Altavilla D., Micali C., et al. Aromatic trap analysis of free radicals production in experimental collagen-induced arthritis in the rat: protective effect of glycosaminoglycans treatment. Free Radic Res 2003, 37:257-268.
250. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006, 85:699-715.
251. Sconocchia G., Campagnano L., Adorno D., Iacona A., Cococcetta N.Y., Boffo V., et al. CD44 ligation on peripheral blood polymorphonuclear cells induces interleukin-6 production. Blood 2001, 97:3621-3627.
252. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005, 11:1173-1179.
253. Yamawaki H., Hirohata S., Miyoshi T., Takahashi K., Ogawa H., Shinohata R., et al. Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology 2009, 19:83-92.
254. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002, 195:99-111.
255. Bollyky P.L., Falk B.A., Wu R.P., Buckner J.H., Wight T.N., Nepom G.T. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J Leukoc Biol 2009, 86:567-572.
256. Day A.J., de la Motte C.A. Hyaluronan cross-linking: a protective mechanism in inflammation?. Trends Immunol 2005, 26:637-643.
257. Schwartz R.H. T cell anergy. Annu Rev Immunol 2003, 21:305-334.